Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership225,164 shares
Latest Disclosed Value $ 380,528
Jane Street Group, Llc ownership in FLNA / Filana Therapeutics, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 225,164 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $380,528 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 513,137 shares of Filana Therapeutics, Inc.. This represents a change in shares of -56.12% during the quarter.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (FLNA) in the form of stock options. The firm currently holds call options representing 82,300 of underlying shares valued at $139,087 USD and put options representing 21,100 of underlying shares valued at $35,659 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:FLNA / Filana Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 225,164 -287,973 -56.12 381 -62.60 0.0000
2026-02-12 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 513,137 317,566 162.38 1,016 78.56 0.0002
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 195,571 -143,029 -42.24 569 -7.03 0.0001
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 338,600 61,765 22.31 613 47.47 0.0001
2025-05-19 2025-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 276,835 -123,404 -30.83 415 -56.04 0.0001
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 276,835 -123,404 415 0.0001
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 400,239 323,306 420.24 945 -58.30 0.0002
2024-11-15 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 76,933 -43,215 -35.97 2,264 52.66 0.0005
2024-08-15 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 120,148 23,761 24.65 1,484 -24.14 0.0003
2024-05-16 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 96,387 -277,819 -74.24 1,956 -76.79 0.0004
2024-02-15 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 374,206 360,686 2,667.80 8,423 3,660.27 0.0022
2023-11-15 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 13,520 -30,470 -69.27 225 -79.22 0.0001
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 43,990 22,434 104.07 1,079 107.71 0.0004
2023-05-16 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 21,556 12,722 144.01 520 99.62 0.0002
2023-02-15 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 8,834 -14,101 -61.48 261 -72.89 0.0001
2022-11-15 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 22,935 7,732 50.86 959 124.07 0.0004
2022-08-16 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 15,203 1,972 14.90 428 -12.83 0.0002
2022-05-17 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 13,231 -95,812 -87.87 491 -89.69 0.0002
2022-02-15 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 109,043 -39,607 -26.64 4,764 -48.37 0.0016
2021-11-16 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 148,650 -26,181 -14.98 9,228 -38.22 0.0033
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 174,831 102,071 140.28 14,938 356.68 0.0058
2021-05-18 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 72,760 16,482 29.29 3,271 751.82 0.0016
2021-02-17 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 56,278 42,546 309.83 384 143.04 0.0002
2020-11-17 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 13,732 -81,222 -85.54 158 -45.89 0.0001
2020-08-17 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 94,954 70,970 295.91 292 194.95 0.0002
2020-05-15 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 23,984 6,715 38.88 99 10.00 0.0001
2020-02-14 2019-12-31 13F CASSAVA SCIENCES COM 14817C107 17,269 3,279 23.44 90 429.41 0.0001
2019-11-14 2019-09-30 13F CASSAVA SCIENCES COM 14817C107 13,990 13,990 17 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F FILANA THERAPEUTICS COM Call 82,300 -15.07 139 -27.23 n/a n/a n/a
2026-02-12 2025-12-31 13F CASSAVA SCIENCES COM Call 96,900 -0.31 192 -32.27 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Call 97,200 118.92 283 252.50 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Call 44,400 -59.53 80 -51.22 n/a n/a n/a
2025-05-19 2025-03-31 13F/A CASSAVA SCIENCES COM Call 109,700 -72.61 165 -82.65 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Call 109,700 165 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Call 400,500 28.94 945 -89.66 n/a n/a n/a
2024-11-15 2024-09-30 13F CASSAVA SCIENCES COM Call 310,600 12.95 9,141 -10.51 n/a n/a n/a
2022-05-17 2022-03-31 13F CASSAVA SCIENCES COM Call 275,000 -59.50 10,214 -65.58 n/a n/a n/a
2022-02-15 2021-12-31 13F CASSAVA SCIENCES COM Call 679,000 -43.38 29,672 -60.15 n/a n/a n/a
2021-11-16 2021-09-30 13F CASSAVA SCIENCES COM Call 1,199,300 201.41 74,453 119.00 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Call 397,900 6.36 33,997 102.17 n/a n/a n/a
2021-05-18 2021-03-31 13F CASSAVA SCIENCES COM Call 374,100 1,526.52 16,816 10,610.83 n/a n/a n/a
2021-02-17 2020-12-31 13F CASSAVA SCIENCES COM Call 23,000 -88.46 157 -93.16 n/a n/a n/a
2020-11-17 2020-09-30 13F CASSAVA SCIENCES COM Call 199,300 2,294 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F FILANA THERAPEUTICS COM Put 21,100 -68.92 36 -73.88 n/a n/a n/a
2026-02-12 2025-12-31 13F CASSAVA SCIENCES COM Put 67,900 559.22 134 362.07 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Put 10,300 -45.21 30 -14.71 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Put 18,800 -91.75 34 -90.06 n/a n/a n/a
2025-05-19 2025-03-31 13F/A CASSAVA SCIENCES COM Put 228,000 -32.68 342 -57.20 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Put 228,000 342 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Put 338,700 -37.57 799 -95.00 n/a n/a n/a
2024-11-15 2024-09-30 13F CASSAVA SCIENCES COM Put 542,500 216.51 15,966 150.79 n/a n/a n/a
2022-05-17 2022-03-31 13F CASSAVA SCIENCES COM Put 171,400 -42.69 6,366 -51.30 n/a n/a n/a
2022-02-15 2021-12-31 13F CASSAVA SCIENCES COM Put 299,100 -56.80 13,071 -69.59 n/a n/a n/a
2021-11-16 2021-09-30 13F CASSAVA SCIENCES COM Put 692,400 168.16 42,984 94.84 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Put 258,200 32.55 22,061 151.95 n/a n/a n/a
2021-05-18 2021-03-31 13F CASSAVA SCIENCES COM Put 194,800 61.79 8,756 966.50 n/a n/a n/a
2021-02-17 2020-12-31 13F CASSAVA SCIENCES COM Put 120,400 -5.42 821 -43.96 n/a n/a n/a
2020-11-17 2020-09-30 13F CASSAVA SCIENCES COM Put 127,300 1,465 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.